# A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers

> **NCT01262170** · PHASE1 · COMPLETED · sponsor: **Rock Creek Pharmaceuticals, Inc.** · enrollment: 109 (actual)

## Conditions studied

- Smoking
- Tobacco Use Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** CigRx Lozenge
- **OTHER:** Tobacco Lozenge

## Key facts

- **NCT ID:** NCT01262170
- **Lead sponsor:** Rock Creek Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2015-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01262170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01262170, "A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01262170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*